Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles-Reference-Cited by-同舟云学术

Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles

Published:2022 Issue:11 Volume:12 Page:6377-6388
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Serda Maciej¹^ORCID,Gawecki Robert²³,Dulski Mateusz⁴,Sajewicz Mieczysław¹,Talik Ewa³,Szubka Magdalena³^ORCID,Zubko Maciej⁴⁵^ORCID,Malarz Katarzyna²³^ORCID,Mrozek-Wilczkiewicz Anna²³,Musioł Robert¹

Affiliation:

1. Institute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, Poland

2. Silesian Center for Education and Interdisciplinary Research, 75 Pulku Piechoty 1a, 41-500 Chorzow, Poland

3. A. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, Poland

4. Institute of Materials Science, University of Silesia in Katowice, 75 Pulku Piechoty, 1A, Chorzow, 41-500, Poland

5. Department of Physics, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Králové, Czech Republic

Abstract

The 5-aminolevulinic acid (5-ALA) prodrug is widely used in clinical applications, primarily for skin cancer treatments and to visualize brain tumors in neurosurgery.

Funder

Narodowe Centrum Nauki

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D1RA08499B

Reference48 articles.

1. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?

2. 5‐ALA in the management of malignant glioma

3. Safety Profile of 5-Aminolevulinic Acid as a Surgical Adjunct in Clinical Practice